- The U.S. Federal Circuit Court reverses the final determination issued by the International Trade Commission that held that Align Technology's (NASDAQ:ALGN) Consent Order was invalid (the '562 case) against OrthoClear and certain individuals involved with ClearCorrect Pakistan. The dispute involves the digital importation of data from Pakistan in order to make ClearCorrect aligners. Align maintains that its Consent Order forbids the action while OrthoClear says that it does not because the language in the contract does not specifically mention electronic transmissions.
- The Federal Circuit agreed with Align that the issue is a procedural matter and that the ITC should never have reviewed and reversed the Administrative Law Judge's ruling.
- The case will now be remanded back to the ITC. Align intends to pursue legal action against the parties for patent infringement.
From other sites
at Nasdaq.com (Mar 25, 2015)
at Zacks.com (Mar 13, 2015)
at Zacks.com (Mar 11, 2015)
at Nasdaq.com (Feb 25, 2015)
at Nasdaq.com (Jan 23, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs